01.10.2010 | Original Paper
Expenditures of the German statutory health insurance system for patients suffering from acute coronary syndrome and treated with percutaneous coronary intervention
Erschienen in: The European Journal of Health Economics | Ausgabe 5/2010
Einloggen, um Zugang zu erhaltenAbstract
Patients with acute coronary syndrome (ACS) are in need of cost-intensive treatment involving different aspects of the German Health System. Percutaneous coronary intervention (PCI) is the treatment of choice for a large proportion of cases. In the present study, an analysis of the cost impact of ACS with focus on PCI therapy was conducted across-the-board for the German Health System. Results indicated that 85% of all costs arising from treatment of ACS with a trial of PCI are due to in-patient care. Projection of results onto the entire insurant collective of the statutory health system estimated a total of €954,995,603—a proportional 0.7% of all expenditure by statutory health insurances in 2005.
Anzeige